K260217

Substantially Equivalent

AI Platform 2.2 (AIP002)

Applicant: Exo Imaging
Product code: QIH
Advisory panel: Radiology
Date received: 2026-01-23
Decision date: 2026-02-24
Decision: Substantially Equivalent
Clearance type: Special
Location: Santa Clara, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.